TAG-72 Antibody (B72.3 (Satumomab)) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-52672PCP
            Recombinant Monoclonal Antibody.
          
         
      Conjugate
              Catalog #
              
            Forumulation
              Catalog #
              
            Key Product Details
Species Reactivity
                  Human
                
                                                                                        Applications
                  Immunohistochemistry, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, CyTOF-ready
                
                                                              Label
            PerCP (Excitation = 490 nm, Emission = 675 nm)
          
        Antibody Source
            Recombinant Monoclonal Rabbit IgG Kappa Clone # B72.3 (Satumomab)
          
        Concentration
            Please see the vial label for concentration. If unlisted please contact technical services.
          
        Product Specifications
Immunogen
                          Tumour-associated glycoprotein 72 is a glycoprotein found on the surface of many cancer cells, including ovary, breast, colon, and pancreatic cells.
                      
        Reactivity Notes
                          Human
                      
        Specificity
                          Recognises human Tumor associated glycoprotein 72.
                      
        Clonality
                          Monoclonal
                      
        Host
                          Rabbit
                      
        Isotype
                          IgG Kappa
                      
        Applications for TAG-72 Antibody (B72.3 (Satumomab)) [PerCP]
          Application
        
        
          Recommended Usage
        
      CyTOF-ready
                                                Optimal dilutions of this antibody should be experimentally determined.
                                                            
                  Flow Cytometry
                                                Optimal dilutions of this antibody should be experimentally determined.
                                                            
                  Immunocytochemistry/ Immunofluorescence
                                                Optimal dilutions of this antibody should be experimentally determined.
                                                            
                  Immunohistochemistry
                                                Optimal dilutions of this antibody should be experimentally determined.
                                                            
                  
        Application Notes
      
      
        Optimal dilution of this antibody should be experimentally determined.
      
    Formulation, Preparation, and Storage
Purification
                          Protein A purified
                      
        Formulation
                          PBS
                      
        Preservative
                          0.05% Sodium Azide
                      
        Concentration
                          Please see the vial label for concentration. If unlisted please contact technical services.
                      
        Shipping
                          The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
                      
        Stability & Storage
                          Store at 4C in the dark.
                      
        Background: TAG-72
Alternate Names
            CA 72-4, Protein TAG-72, tag 72, tag-72 Protein TAG-72
          
        Additional TAG-72 Products
Product Documents for TAG-72 Antibody (B72.3 (Satumomab)) [PerCP]
Product Specific Notices for TAG-72 Antibody (B72.3 (Satumomab)) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
    Loading...
  
    Loading...
  
    Loading...
  
    Loading...
  
    Loading...
  
Loading...